Page last updated: 2024-10-29

iopromide and Cancer of Parotid

iopromide has been researched along with Cancer of Parotid in 2 studies

iopromide: structure given in first source
iopromide : A dicarboxylic acid diamide that consists of N-methylisophthalamide bearing three iodo substituents at positions 2, 4 and 6, a methoxyacetyl substituent at position 5 and two 2,3-dihydroxypropyl groups attached to the amide nitrogens. A water soluble x-ray contrast agent for intravascular administration.

Research Excerpts

ExcerptRelevanceReference
"The TDC of basal cell adenomas had a fast ascension followed by a plateau, then a gradual descent."1.40Diagnostic value of CT perfusion imaging for parotid neoplasms. ( Dong, Y; Ge, Y; Lei, GW; Wang, SW; Wei, FC; Zheng, SW, 2014)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dong, Y1
Lei, GW1
Wang, SW1
Zheng, SW1
Ge, Y1
Wei, FC1
Jin, GQ1
Su, DK1
Xie, D1
Zhao, W1
Liu, LD1
Zhu, XN1

Other Studies

2 other studies available for iopromide and Cancer of Parotid

ArticleYear
Diagnostic value of CT perfusion imaging for parotid neoplasms.
    Dento maxillo facial radiology, 2014, Volume: 43, Issue:1

    Topics: Adenolymphoma; Adenoma; Adenoma, Pleomorphic; Adult; Aged; Aged, 80 and over; Blood Volume; Capillar

2014
Distinguishing benign from malignant parotid gland tumours: low-dose multi-phasic CT protocol with 5-minute delay.
    European radiology, 2011, Volume: 21, Issue:8

    Topics: Adenolymphoma; Adenoma, Pleomorphic; Adult; Aged; Analysis of Variance; Contrast Media; Diagnosis, D

2011